Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Intangibles (2016 - 2021)

Assembly Biosciences (ASMB) has 7 years of Intangibles data on record, last reported at $29.0 million in Q3 2021.

  • For Q3 2021, Intangibles changed 0.0% year-over-year to $29.0 million; the TTM value through Sep 2021 reached $29.0 million, changed 0.0%, while the annual FY2020 figure was $29.0 million, 0.0% changed from the prior year.
  • Intangibles reached $29.0 million in Q3 2021 per ASMB's latest filing, roughly flat from $29.0 million in the prior quarter.
  • Across five years, Intangibles topped out at $29.0 million in Q1 2017 and bottomed at $29.0 million in Q1 2017.
  • Average Intangibles over 5 years is $29.0 million, with a median of $29.0 million recorded in 2017.
  • The widest YoY moves for Intangibles: up 0.0% in 2017, down 0.0% in 2017.
  • A 5-year view of Intangibles shows it stood at $29.0 million in 2017, then changed by 0.0% to $29.0 million in 2018, then changed by 0.0% to $29.0 million in 2019, then changed by 0.0% to $29.0 million in 2020, then changed by 0.0% to $29.0 million in 2021.
  • Per Business Quant database, its latest 3 readings for Intangibles were $29.0 million in Q3 2021, $29.0 million in Q2 2021, and $29.0 million in Q1 2021.